For: | Zhou ML, Xu RN, Tan C, Zhang Z, Wan JF. Advanced gastric cancer achieving major pathologic regression after chemoimmunotherapy combined with hypofractionated radiotherapy: A case report. World J Gastrointest Oncol 2023; 15(6): 1096-1104 [PMID: 37389115 DOI: 10.4251/wjgo.v15.i6.1096] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v15/i6/1096.htm |
Number | Citing Articles |
1 |
Mimi Xu, Yafei Zhang, Kui Zhao, Haiping Jiang, Guangfa Wang, Yan Wu, Yu Wang, Nian Liu, Xinhui Su. Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment 18F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13765-1
|
2 |
Fuping Gao, Xiaohua Zhou, Jin Wei, Qiong Sun, Jiapeng Wang, Qing Li. Expression characteristics and biological functions of CGB5 gene in gastric cancer. Acta Histochemica 2025; 127(2): 152254 doi: 10.1016/j.acthis.2025.152254
|
3 |
Huizi Li, Jiaobao Huang, Kuntang Liu, Jibiao Liu, Queling Liu, Zhiyong Zhou, Zhen Zong, Shengxun Mao. ChatGPT-4o outperforms gemini advanced in assisting multidisciplinary decision-making for advanced gastric cancer. European Journal of Surgical Oncology 2025; 51(8): 110096 doi: 10.1016/j.ejso.2025.110096
|